As of Feb 20, 2025, Acadia Healthcare Company, Inc.'s fair value using the Peter Lynch formula is N/A per share. The current price of $40.8 suggests Acadia Healthcare Company, Inc. may be overvalued by this metric.

What is Acadia Healthcare Company, Inc. Price to Earnings (P/E) ratio?

As of Feb 20, 2025, Acadia Healthcare Company, Inc.'s P/E ratio is 13.4x. This is calculated by dividing the current share price of $40.8 by the Earnings per Share (EPS) for the trailing twelve months, which is $3.1. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Acadia Healthcare Company, Inc. earnings per share (EPS)?

Acadia Healthcare Company, Inc. earnings per share (EPS) for the twelve months ending Feb 20, 2025, was $3.1, a N/A growth year-over-year.